Infobox drug/sandbox (edit · t · history · diff · links · /test · Source · e · t · hist · links · /subpages · /doc · /doc edit )
/testcases2 -- titles, licence, EMA
/testcases3 -- pregcat, legal, licence, PLLR, ATC; Wikidata
/testcases4 -- chem formula, mab
/testcases5 -- identifiers, second id's
/testcases6 -- all up
/testcases7images -- images
/testcases8 -- type, titles
/testcases9 -- order variants, container_only
/testcases10 -- pharmacokinetic, localINN (2017) has (data page) -- is a redirect
/testcases11 -- hormone, gene therapy (2018) , has (data page)
/testcases-FDA -- FDA 2023
/testcases-warning -- warning box(es)
Current test: Licence, title Side by side comparison ((Infobox drug )) ((Infobox drug/sandbox ))
Riboflavin Chemical structure
Trade names Many[ 1] Other names lactochrome, lactoflavin, vitamin G AHFS /Drugs.com Monograph License data
Routes of administration By mouth , intramuscular , intravenous ATC code Legal status
Elimination half-life 66 to 84 minutes Excretion Urine
7,8-Dimethyl-10-[(2S ,3S ,4R )-2,3,4,5-tetrahydroxypentyl]benzo[g ]pteridine-2,4-dione
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) Formula C 17 H 20 N 4 O 6 Molar mass 376.369 g·mol−1 3D model (JSmol )
c12cc(C)c(C)cc1N=C3C(=O)NC(=O)N=C3N2C[C@H](O)[C@H](O)[C@H](O)CO
InChI=InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
Y Key:AUNGANRZJHBGPY-SCRDCRAPSA-N
Y
Riboflavin Chemical structure
Trade names Many[ 1] Other names lactochrome, lactoflavin, vitamin G AHFS /Drugs.com Monograph License data
Routes of administration By mouth , intramuscular , intravenous ATC code Legal status
Elimination half-life 66 to 84 minutes Excretion Urine
7,8-Dimethyl-10-[(2S ,3S ,4R )-2,3,4,5-tetrahydroxypentyl]benzo[g ]pteridine-2,4-dione
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEBI ChEMBL CompTox Dashboard (EPA ) Formula C 17 H 20 N 4 O 6 Molar mass 376.369 g·mol−1 3D model (JSmol )
c12cc(C)c(C)cc1N=C3C(=O)NC(=O)N=C3N2C[C@H](O)[C@H](O)[C@H](O)CO
InChI=InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1
Y Key:AUNGANRZJHBGPY-SCRDCRAPSA-N
Y
Drop EMA link for now (07-2021)[ edit ] (( Infobox drug ))
(( Infobox drug/licence )) Tegafur/gimeracil/oteracil (~random)Purge
Side by side comparison ((Infobox drug )) ((Infobox drug/sandbox ))
Infobox drug/testcases2INN : Linezolid Pronunciation Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS /Drugs.com Monograph MedlinePlus a602004 License data
Pregnancy category Dependence liability High Addiction liability Low Routes of administration Intravenous infusion , oralATC code Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved)Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal , and fecal
(S )-N -({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEMBL NIAID ChemDB PDB ligand Formula C 16 H 20 F N 3 O 4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol ) Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C)
O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N
Y
N Y (what is this?) (verify)
Infobox drug/testcases2INN : Linezolid Pronunciation Trade names Linospan, Zyvox, Zyvoxam, Zyvoxid Other names Lenzomore AHFS /Drugs.com Monograph MedlinePlus a602004 License data
Pregnancy category Dependence liability High Addiction liability Low Routes of administration Intravenous infusion , oralATC code Bioavailability ~100% (oral) Protein binding Low (31%) Metabolism Hepatic (50–70%, CYP not involved)Metabolites some stuff Onset of action 1 hr Elimination half-life 4.2–5.4 hours (shorter in children) Duration of action 1 to 3 hr Excretion Nonrenal, renal , and fecal
(S )-N -({3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide
CAS Number PubChem CID IUPHAR/BPS DrugBank ChemSpider UNII KEGG ChEMBL NIAID ChemDB PDB ligand Formula C 16 H 20 F N 3 O 4 Molar mass 337.346 g/mol g·mol−1 3D model (JSmol ) Density 1.40 g/cm3 Melting point 135 °C (275 °F) Boiling point 140 °C (284 °F) (decomposes) Solubility in water 3 mg/mL (20 °C)
O=C1O[C@@H](CNC(=O)C)CN1c3cc(F)c(N2CCOCC2)cc3
InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1
Y Key:TYZROVQLWOKYKF-ZDUSSCGKSA-N
Y
N Y (what is this?) (verify)
Purge
English language variants: Licence or License [ edit ] See also WP:ENGVAR : english language variant of the article
In ((Infobox drug)) : spelling of licence/license . Default is to be en-US: License .
Use parameter |engvar=
for non-default spelling:
Default licenSe (US) |engvar=en-US
licenSe |engvar=en-UK
licenCe |engvar=en-NZ
licenCe NOWIKI FOR SPEED (July 2021)[ edit ]
==Titletests (default, INN, drug_name)==
===Lysergide (LSD)===
((Purge)) Reduced infobox.
:Current infobox title: ((strong|1=Lysergic acid diethylamide)) (pagename, not INN)
:New situation would be (adding "(LSD)" is just a liberty I took, to help our readers):
((Testcase table
| drug_name=Lysergic acid diethylamide (LSD)
| INN = Lysergide
| IUPAC_name = (6a''R'',9''R'')-''N'',''N''-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-''fg'']quinoline-9-carboxamide
| image = LSD-2D-skeletal-formula-and-3D-models.png
<!--Clinical data-->
| pregnancy_US = C
| legal_AU = Schedule 9
| legal_CA = Schedule III
| legal_NZ = Class A
| legal_UK = Class A
| legal_UN = P I
| legal_US = Schedule I
| legal_DE = Anlage I
| addiction_liability = None
| dependency_liability = Low
| routes_of_administration = [[Oral administration|Oral]], etc
<!--Pharmacokinetic data-->
| metabolism = Hepatic
| elimination_half-life = 3–5 hours
| excretion = [[Renal]]
<!--Identifiers-->
| CAS_number = 50-37-3
| ChEBI = 6605
| PubChem = 5761
| IUPHAR_ligand = 17
| DrugBank = DB04829
| ChemSpiderID = 5558
| UNII = 8NA5SWF92O
| ChEMBL = 263881
| ATC_prefix = none
<!--Chemical data-->
| C=20 | H=25 | N=3 | O=1
| synonyms = Acid, LSD, lysergide
))
=== (regular)===
* [[alpha-Methyltryptamine]]
: No need to use ((para|INN)). Note the titletext (mousehover).
((Testcase table
| IUPAC_name = 2-(1''H''-indol-3-yl)-1-methyl-ethylamine
| image = AMT.svg
| width = 150px
| drug_name = α-Methyltryptamine
<!--Clinical data-->
| routes_of_administration = [[Mouth|Oral]]
<!--Identifiers-->
| CAS_number = 299-26-3
| ATC_prefix = none
| ATC_suffix =
<!--Chemical data-->
| C=11 | H=14 | N=2
| synonyms = Indopan; IT-290, IT-403, U-14,164E, 3-IT
))
===Default Title===
((testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
))
((testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
))
((testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
))
((testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
))
==Test INN==
((testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = inn
))
((testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = inn
))
((testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = inn
))
((testcase table
| drug_name = Aspirin [[Main page|MP]]
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = inn
))
;blanks
((testcase table
| drug_name =
| CAS_number =
| trade_names=
| INN =
))
===INN=none===
((testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
))
((testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
))
((testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
))
((testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
))
===INN=some sense===
((testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = inn
))
((testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = inn
))
((testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = inn
))
((testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = inn
))
===INN='none'===
((testcase table
| CAS_number = 1234-56-7
| trade_names=no dn
| INN = none
))
((testcase table
| drug_name =
| CAS_number = 1234-56-7
| trade_names=blank dn
| INN = none
))
((testcase table
| drug_name = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
| INN = None
))
((testcase table
| drug_name = Aspirin
| CAS_number = 1234-56-7
| trade_names=dn is diff
| INN = none
))
===INN eq===
((testcase table
| drug_name = Infobox drug/testcases8
| INN = Infobox drug/testcases8
| CAS_number = 1234-56-7
| trade_names = dn=pagenm
))
==All blank==
((testcase table
| no_param_name=99
))
==All up==
((purge))
((Testcase table
| type = IUPAC
| drug_name = 1/IUPAC
| captionLR = Cap LR
| imageL = L1 barcelona.svg
| imageR = Tabliczka_R1.svg
| widthL = 70px
| widthR = 90px
| altL = alt-L
| altR = alt-R
| Watchedfields = 103
| imagename = 2
| image = Racemic amphetamine 2.svg
| width = 175px
| alt = an example image
| image2 = D-Amphetamine-3D-balls.png
| width2 = 150px
| alt2 = another example image
| caption = some images
| IUPAC_name = 12
| trivial_name = some-name
| target = 13
| vaccine_type = Toxoid
| mab_type = F(ab')2
| source = xi/a
| component1 = 17
| class1 = 18
| component2 = 19
| class2 = 20
| component3 = 21
| class3 = 22
| component4 = 23
| class4 = 24
| tradename = 25
| tradename_pronunciation = twenty-five
| tradename_synonym = two dozen plus one
| Drugs.com = 27
| MedlinePlus = 29
| licence_CA = 29.5
| licence_EU = 30
| licence_US = 31
| DailyMedID = 32
| pregnancy_AU = B3
| pregnancy_US = C
| pregnancy_category = 35
| legal_AU = S4
| legal_CA = Schedule IV
| legal_UK = POM
| legal_US = Schedule III
| legal_UN = N II III
| legal_EU = Category 2 Precursor
| legal_status = RX
| dependency_liability = 43-1
| addiction_liability = 43-2
| routes_of_administration = 44
| bioavailability = 45
| protein_bound = 46
| metabolism = 47
| onset = 47.5
| elimination_half-life = 48
| excretion = 49
| CAS_number = 50
| CAS_number_Ref = 51
| CAS_supplemental = 52
| ATCvet = 53
| ATC_prefix = 54
| ATC_suffix = 55
| ATC_supplemental = 56
| PubChem = 57
| PubChemSubstance = 58
| IUPHAR_ligand = 59
| DrugBank = 60
| DrugBank_Ref = 101
| ChemSpiderID = 61
| ChemSpiderID_Ref = 62
| UNII = 63
| UNII_Ref = 64
| KEGG = 65
| KEGG_Ref = 66
| ChEBI = 67
| ChEBI_Ref = 68
| ChEMBL = 69
| ChEMBL_Ref = 70
| NIAID_ChemDB = 71
| synonyms = 72
| PDB_ligand = 73
| chemical_formula =
| C = 1
| H = 2
| Ag = 3
| Al = 4
| As = 5
| Au = 6
| B = 7
| Bi = 8
| charge = -1
| molecular_weight = 75
| show_all=yes
| smiles = 76
| StdInChI = 77
| StdInChI_comment = 78
| StdInChI_Ref = 79
| StdInChIKey = 80
| StdInChIKey_comment = 81
| StdInChIKey_Ref = 82
| density = 83
| melting_point = 84
| melting_high = 85
| melting_notes = 86
| boiling_point = 87
| boiling_high = 104
| boiling_notes = 88
| solubility = 89
| chirality = 106
| specific_rotation = 90
| sec_combustion = 91
| Verifiedfields = 92
| verifiedrevid = 93
))
((purge)) (reduced infobox)
:Current infobox title: ((strong|1= Diamorphine (((abbr|INN|International Nonproprietary Name)))))
: The new situation required an edit.
((testcase table
| drug_name = Heroin
| INN = Diamorphine
| IUPAC_name = (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate
| image = Heroin - Heroine.svg
| image2 = Heroin-from-xtal-horizontal-3D-balls.png
<!--Clinical data-->
| pronounce = ((IPAc-en|ˈ|h|ɛ|r|o:|ɪ|n))
| Drugs.com = ((drugs.com|parent|heroin))
| legal_AU = S9
| dependency_liability = Physical: Very high<br />Psychological: Very high
| addiction_liability = Very high
| routes_of_administration = Inhalation, transmucosal, intravenous, oral, intranasal, rectal, intramuscular
<!--Identifiers-->
| CAS_number_Ref = ((cascite|correct|??))
| CAS_number = 561-27-3
| ATC_prefix = N07
| ATC_suffix = BC06
| ChEBI_Ref = ((ebicite|correct|EBI))
| ChEBI = 27808
| PubChem = 5462328
| DrugBank_Ref = ((drugbankcite|correct|drugbank))
| DrugBank = DB01452
| ChemSpiderID_Ref = ((chemspidercite|correct|chemspider))
| ChemSpiderID = 4575379
| UNII_Ref = ((fdacite|correct|FDA))
| UNII = 8H672SHT8E
| ChEMBL_Ref = ((ebicite|correct|EBI))
| ChEMBL = 459324
<!--Chemical data-->
| C=21 | H=23 | N=1 | O=5
| molecular_weight = 369.41 g/mol
| synonyms = Diamorphine, Diacetylmorphine, Acetomorphine, (Dual) Acetylated morphine, Morphine diacetate
))